Skip to content

Combined Lumbosacral Nerve Block Versus Spinal Anesthesia for Cognitive Function After Hip Prothesis

Cognitive Changes After Hip Prosthesis; Comparison Between Combined Lumbosacral Nerve Block Versus Spinal Anesthesia: a Double Blind Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03794427
Enrollment
50
Registered
2019-01-07
Start date
2019-01-02
Completion date
2022-04-30
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Decline

Brief summary

Hip fracture is a potentially devastating event, and serious surgical and medical complications occur frequently especially for elderly patients. Delirium is one of the common complications after hip surgery. Controversy exists regarding the possible impact of type of anesthesia (nerve block versus spinal) upon acute and long-term cognitive decline. The primary objective is to assess the association between type of anesthesia (nerve block vs. spinal anesthesia) and risk of cognitive decline (CD). The secondary objective is to compare intra-operative hemodynamic changes, use of vasopressor drugs, and use of post-operative analgesics with respect to the type of anesthesia. Prospective, double blind randomized clinical trial of hip fracture patients who will be assessed for CD pre- and postoperatively, using the Mini Mental State Examination (MMSE). The presence of CD will be determined at follow-up evaluation up to three months after surgery.

Detailed description

Prospective, double blind randomized clinical trial of hip fracture patients who will be assessed for CD pre- and postoperatively, using the Mini Mental State Examination (MMSE). The presence of CD will be determined at follow-up evaluation up to three months after surgery. Patients undergoing hip surgery will be randomized into two groups. Group 1 will receive unilateral lumbosacral nerve block (sciatic nerve block and paravertebral block at levels L3-L4 and L4-L5) as well as placebo injection (1 ml normal saline) at the spinal anesthesia level (L3-L4 or L4-L5). The sciatic nerve will be injected by 20 ml of the anesthetic mixture whereas levels L3-L4 and L4-L5 will be injected by a total of 20 ml of the anesthetic mixture without exceeding the maximum injected volume of 1 ml/kg. Group 2 will receive spinal anesthesia (3 ml of 0.5% bupivacaine) in addition to placebo injection at the sciatic, L3-L4 and L4-L5 levels.

Interventions

OTHERunilateral lumbosacral nerve block

Patients will receive unilateral lumbosacral nerve block (sciatic nerve block and paravertebral block at levels L3-L4 and L4-L5). The sciatic nerve will be injected by 20 ml of the anesthetic mixture whereas levels L3-L4 and L4-L5 will be injected by a total of 20 ml of the anesthetic mixture without exceeding the maximum injected volume of 1 ml/kg.

OTHERSpinal anesthesia

Patients will receive spinal anesthesia (3 ml of 0.5% bupivacaine)

OTHERPlacebo at the spinal anesthesia level

Patients will receive 1 ml normal saline at the spinal anesthesia level (L3-L4 or L4-L5).

OTHERPlacebo at lumbosacral level

Patients will receive normal saline at the sciatic, L3-L4 and L4-L5 levels

Sponsors

Makassed General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted with a hip fracture (femoral neck, trochanteric or sub-trochanteric) * 40 kg in weight and higher

Exclusion criteria

Patients who are: * Uncooperative * Considered as moribund by the orthopedic surgeon at admission * Alzheimer * Severe cognitive impairment (MMSE\<18) * Absolute contraindication for spinal anesthesia (assessed preoperatively) * Allergy to local anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Cognitive declinebefore operation (baseline)Patients' cognitive function will be assessed using the Mini Mental State Examination. The total score ranges between 0 and 30. A total score between 24 and 30 indicates no cognitive impairment. A score between 18 and 23 indicates mild cognitive impairment. A score between 0 and 17 indicates severe cognitive impairment

Secondary

MeasureTime frameDescription
Intra-operative hemodynamic changes1 minute intra-operativeMean arterial pressure (in mmHg) will be recorded through a questionnaire

Countries

Lebanon

Contacts

Primary ContactZoher Naja
zouhnaja@yahoo.com+9611636000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026